PharmaKure

PharmaKure is a clinical-stage pharmaceutical company primarily targeting neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and other rare conditions. The company’s proprietary technology enables the diagnosis and monitoring of patient treatment using blood-based biomarkers. Our drug candidates mainly target neurotoxic proteins that cause these diseases. Biomarkers monitor treatment efficacy by measuring changes in the levels of these biomarkers in patients’ blood. This integrated approach is unique and aids in the development of current and future therapies, with the aim of rapidly bringing cost-effective treatments to market.